INOGEN, INC.

INGN ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $348.7M $335.7M $315.7M $377.2M $358.0M $308.5M $361.9M $358.1M
Cost of Revenue $194.4M $181.0M $189.0M $223.7M $181.5M $170.3M $190.1M $179.5M
Gross Profit $154.3M $154.7M $126.7M $153.5M $176.5M $138.2M $171.9M $178.6M
Gross Margin 44.2% 46.1% 40.1% 40.7% 49.3% 44.8% 47.5% 49.9%
Operating Expenses
Research & Development $19.4M $21.6M $20.8M $21.9M $16.6M $14.1M $9.4M $7.0M
SG&A Expense $67.4M $72.6M $75.3M $43.9M $37.9M $38.6M $37.1M $38.0M
Operating Income $-30.2M $-42.5M $-109.4M $-85.2M $9.2M $-12.0M $19.8M $37.9M
Operating Margin -8.7% -12.7% -34.7% -22.6% 2.6% -3.9% 5.5% 10.6%
Interest Expense
Pretax Income $-23.4M $-36.5M $-102.3M $-83.3M $8.7M $-5.3M $24.3M $40.5M
Income Tax Expense $-632.0K $-588.0K $105.0K $504.0K $15.0M $549.0K $3.3M $-11.4M
Net Income $-22.7M $-35.9M $-102.4M $-83.8M $-6.3M $-5.8M $21.0M $51.8M
Net Margin -6.5% -10.7% -32.5% -22.2% -1.8% -1.9% 5.8% 14.5%
EPS (Basic) $-0.86 $-1.52 $-4.42 $-3.67 $-0.28 $-0.27 $0.96 $2.44
EPS (Diluted) $-0.86 $-1.52 $-4.42 $-3.67 $-0.28 $-0.27 $0.94 $2.30
Shares Outstanding (Basic) 26.6M 23.7M 23.2M 22.9M 22.5M 22.0M 21.8M 21.3M
Shares Outstanding (Diluted) 26.6M 23.7M 23.2M 22.9M 22.5M 22.0M 22.2M 22.5M
Dividends Per Share
← Newer Page 1 of 2 Older →